FDA OKs expanded use of Roche's Avastin for colon cancer treatment

01/23/2013 | American City Business Journals · Fox Business

The FDA authorized the use of Roche Holding's Avastin, or bevacizumab, with fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin chemotherapy, for patients with metastatic colorectal cancer whose condition worsened after previous treatment with the drug. Avastin was developed by Roche unit Genentech.

View Full Article in:

American City Business Journals · Fox Business

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA